Quantum Biopharma Ltd (QNTM)

$5.47 +0.27 (5.19%)
Market Cap 19.85M
Revenue (ttm) 0.00
Net Income (ttm) -26.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 155,400
Avg Vol 515,514
Day's Range N/A - N/A
Shares Out 3.82M
Stochastic %K 56%
Beta 0.29
Analysts Sell
Price Target $35.50

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical enti...

Industry: Biotechnology
Sector: Healthcare
Phone: 833 571 1811
Address:
1 Adelaide Street East, Suite 801, Toronto, Canada
TonyFish
TonyFish May. 14 at 2:43 PM
$GNS $QNTM up 22% JS
0 · Reply
GPDL
GPDL May. 14 at 2:38 PM
$QNTM Glad the market is starting to realize how undervalued this is. Low float
0 · Reply
Vapor83
Vapor83 May. 14 at 2:30 PM
$QNTM just wait until trial start news - that will be a great day
0 · Reply
Smartacusnot
Smartacusnot May. 14 at 2:25 PM
$QNTM
0 · Reply
Ericmao
Ericmao May. 14 at 1:39 PM
$QNTM breaking out now ! $SRXH $SKLZ
0 · Reply
Ericmao
Ericmao May. 14 at 1:32 PM
$SRXH $SKLZ $QNTM bullish !!!
0 · Reply
GPDL
GPDL May. 13 at 6:20 PM
$QNTM Nice cup and handle
0 · Reply
MorganHoratio
MorganHoratio May. 13 at 5:13 PM
Top quantum names to watch:(PART3) ETF exposure: • $QTUM.X • $QNTM • $CHPX Don’t want to gamble on a single tech path? These ETFs are your "Strategic Shield"! 🚀 $QTUM.X just surpassed $4B in AUM, and its 35% YTD return proves the smart money is pouring in. $CHPX is also a powerhouse, capturing the synergy between semiconductors and quantum in the 2nm era. As a fellow holder, I believe ETFs are the safest bet for the 2026 quantum boom. Are you backing the diversified approach of $QTUM.X or leaning towards more hardware-centric plays? Let’s discuss in the comments! 👇
1 · Reply
Vapor83
Vapor83 May. 12 at 3:05 PM
$QNTM trial news any day now (positive news) and the second IR firm starts Monday.
0 · Reply
Rambler1111
Rambler1111 May. 11 at 7:21 PM
$QNTM It’s been very QUIET for a company who announced they hired a PR company a few weeks ago. I really hope they unleash some big news soon and justify the reason they were hired .
0 · Reply
Latest News on QNTM
Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

Thu, 07 May 2026 07:00:00 -0400 - 7 days ago

Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

Quantum BioPharma Provides Corporate Update

Mon, 27 Apr 2026 19:45:00 -0400 - 16 days ago

Quantum BioPharma Provides Corporate Update

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

Wed, 22 Apr 2026 09:16:00 -0400 - 22 days ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

Quantum BioPharma submits Lucid-21-302 new drug application to the FDA

2026-04-01T12:25:14.000Z - 6 weeks ago

Quantum BioPharma submits Lucid-21-302 new drug application to the FDA

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

Wed, 01 Apr 2026 08:02:00 -0400 - 6 weeks ago

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

2026-03-30T12:47:57.000Z - 6 weeks ago

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

2026-03-30T12:28:19.000Z - 6 weeks ago

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis

Mon, 30 Mar 2026 07:50:00 -0400 - 6 weeks ago

Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis

Quantum Biopharma Provides Corporate Update

Fri, 27 Mar 2026 19:30:00 -0400 - 6 weeks ago

Quantum Biopharma Provides Corporate Update

Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status

Fri, 27 Mar 2026 08:10:00 -0400 - 6 weeks ago

Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status

Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

Mon, 23 Mar 2026 08:24:00 -0400 - 7 weeks ago

Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering

Fri, 20 Mar 2026 19:35:00 -0400 - 7 weeks ago

Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering

Quantum BioPharma Provides Corporate Update

Wed, 11 Mar 2026 19:55:00 -0400 - 2 months ago

Quantum BioPharma Provides Corporate Update

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Thu, 19 Feb 2026 19:29:00 -0500 - 2 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Thu, 19 Feb 2026 12:00:00 -0500 - 2 months ago

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma, Ltd. Investors

Tue, 17 Feb 2026 13:55:00 -0500 - 3 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma, Ltd. Investors

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Tue, 17 Feb 2026 12:59:00 -0500 - 3 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Portnoy Law Firm Announces Class Action on Behalf of Quantum Corporation Investors

Tue, 17 Feb 2026 09:41:00 -0500 - 3 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Corporation Investors

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Thu, 12 Feb 2026 16:02:00 -0500 - 3 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Tue, 03 Feb 2026 13:12:00 -0500 - 3 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors

Mon, 02 Feb 2026 10:46:00 -0500 - 3 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Tue, 27 Jan 2026 13:42:00 -0500 - 3 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

Dec 23, 2025, 8:00 AM EST - 5 months ago

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

Mon, 22 Dec 2025 09:00:00 -0500 - 5 months ago

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

Dec 10, 2025, 8:00 PM EST - 5 months ago

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

Quantum BioPharma announces airing of news segment on manipulation lawsuit

2025-12-01T12:15:18.000Z - 5 months ago

Quantum BioPharma announces airing of news segment on manipulation lawsuit

Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC

Nov 27, 2025, 4:00 PM EST - 5 months ago

Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC

Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

Nov 26, 2025, 9:30 AM EST - 6 months ago

Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

Quantum BioPharma reports Q3 EPS ($1.25) vs. (4.37) last year

2025-11-07T12:12:42.000Z - 6 months ago

Quantum BioPharma reports Q3 EPS ($1.25) vs. (4.37) last year

Quantum BioPharma sees cash runway beyond March 2027

2025-11-07T12:11:35.000Z - 6 months ago

Quantum BioPharma sees cash runway beyond March 2027

Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Nov 7, 2025, 7:00 AM EST - 6 months ago

Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Quantum BioPharma Ltd. Provides Corporate Update

Oct 31, 2025, 7:51 PM EDT - 6 months ago

Quantum BioPharma Ltd. Provides Corporate Update

Quantum BioPharma Ltd. Announces Corporate Updates

Oct 29, 2025, 9:00 PM EDT - 7 months ago

Quantum BioPharma Ltd. Announces Corporate Updates

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

Oct 23, 2025, 8:15 AM EDT - 7 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

Quantum BioPharma announces expiration of warrants held by hedge funds

2025-10-20T12:40:40.000Z - 7 months ago

Quantum BioPharma announces expiration of warrants held by hedge funds

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

Oct 20, 2025, 8:30 AM EDT - 7 months ago

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

Oct 14, 2025, 8:15 AM EDT - 7 months ago

Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM

Oct 9, 2025, 6:00 PM EDT - 7 months ago

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

Oct 9, 2025, 5:40 PM EDT - 7 months ago

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

Quantum BioPharma offers cash reward up to $7M for market manipulation proof

2025-10-08T12:15:28.000Z - 7 months ago

Quantum BioPharma offers cash reward up to $7M for market manipulation proof

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Oct 8, 2025, 8:00 AM EDT - 7 months ago

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

Oct 7, 2025, 11:00 AM EDT - 7 months ago

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

Quantum BioPharma announces record date for special dividend distribution

2025-10-03T11:10:25.000Z - 7 months ago

Quantum BioPharma announces record date for special dividend distribution

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

Oct 3, 2025, 7:00 AM EDT - 7 months ago

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

Quantum BioPharma receives final reports for two studies of Lucid-21-302

2025-10-02T12:00:38.000Z - 8 months ago

Quantum BioPharma receives final reports for two studies of Lucid-21-302

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

Oct 2, 2025, 7:57 AM EDT - 8 months ago

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

Quantum BioPharma appoints Jack Antel as clinical development advisor

2025-10-01T11:55:37.000Z - 8 months ago

Quantum BioPharma appoints Jack Antel as clinical development advisor

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

Oct 1, 2025, 7:50 AM EDT - 8 months ago

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

Quantum BioPharma announces Annual General, Special Meeting results

2025-09-29T11:45:06.000Z - 8 months ago

Quantum BioPharma announces Annual General, Special Meeting results

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Sep 29, 2025, 7:40 AM EDT - 8 months ago

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Quantum BioPharma Announces Corporate Updates

Sep 26, 2025, 8:00 PM EDT - 8 months ago

Quantum BioPharma Announces Corporate Updates

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Sep 24, 2025, 8:30 AM EDT - 8 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Sep 18, 2025, 8:10 AM EDT - 8 months ago

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Sep 12, 2025, 7:50 AM EDT - 8 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Sep 10, 2025, 7:00 AM EDT - 8 months ago

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 11, 2025, 6:32 PM EDT - 9 months ago

Quantum BioPharma Announces Update to Previously Announced Private Placement

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Aug 11, 2025, 7:40 AM EDT - 9 months ago

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Quantum BioPharma announces results from study on PET tracer

2025-08-08T12:10:18.000Z - 9 months ago

Quantum BioPharma announces results from study on PET tracer

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Aug 8, 2025, 8:00 AM EDT - 9 months ago

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Aug 7, 2025, 7:00 AM EDT - 10 months ago

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Aug 5, 2025, 7:34 AM EDT - 10 months ago

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Aug 4, 2025, 7:33 AM EDT - 10 months ago

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Jul 31, 2025, 7:24 AM EDT - 10 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

Jul 22, 2025, 7:00 AM EDT - 10 months ago

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

GME

Quantum BioPharma Announces Private Placement

Jun 27, 2025, 4:30 PM EDT - 11 months ago

Quantum BioPharma Announces Private Placement

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Jun 26, 2025, 7:30 AM EDT - 11 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Jun 18, 2025, 9:19 AM EDT - 11 months ago

Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

Jun 17, 2025, 8:00 AM EDT - 11 months ago

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Jun 13, 2025, 7:00 AM EDT - 11 months ago

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Quantum BioPharma Clarifies It Has Not Changed Its Name

Jun 3, 2025, 7:50 AM EDT - 1 year ago

Quantum BioPharma Clarifies It Has Not Changed Its Name

iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients

Jun 2, 2025, 1:47 PM EDT - 1 year ago

iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

May 30, 2025, 7:00 AM EDT - 1 year ago

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

May 29, 2025, 7:30 AM EDT - 1 year ago

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome

May 28, 2025, 8:00 AM EDT - 1 year ago

Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome

TonyFish
TonyFish May. 14 at 2:43 PM
$GNS $QNTM up 22% JS
0 · Reply
GPDL
GPDL May. 14 at 2:38 PM
$QNTM Glad the market is starting to realize how undervalued this is. Low float
0 · Reply
Vapor83
Vapor83 May. 14 at 2:30 PM
$QNTM just wait until trial start news - that will be a great day
0 · Reply
Smartacusnot
Smartacusnot May. 14 at 2:25 PM
$QNTM
0 · Reply
Ericmao
Ericmao May. 14 at 1:39 PM
$QNTM breaking out now ! $SRXH $SKLZ
0 · Reply
Ericmao
Ericmao May. 14 at 1:32 PM
$SRXH $SKLZ $QNTM bullish !!!
0 · Reply
GPDL
GPDL May. 13 at 6:20 PM
$QNTM Nice cup and handle
0 · Reply
MorganHoratio
MorganHoratio May. 13 at 5:13 PM
Top quantum names to watch:(PART3) ETF exposure: • $QTUM.X • $QNTM • $CHPX Don’t want to gamble on a single tech path? These ETFs are your "Strategic Shield"! 🚀 $QTUM.X just surpassed $4B in AUM, and its 35% YTD return proves the smart money is pouring in. $CHPX is also a powerhouse, capturing the synergy between semiconductors and quantum in the 2nm era. As a fellow holder, I believe ETFs are the safest bet for the 2026 quantum boom. Are you backing the diversified approach of $QTUM.X or leaning towards more hardware-centric plays? Let’s discuss in the comments! 👇
1 · Reply
Vapor83
Vapor83 May. 12 at 3:05 PM
$QNTM trial news any day now (positive news) and the second IR firm starts Monday.
0 · Reply
Rambler1111
Rambler1111 May. 11 at 7:21 PM
$QNTM It’s been very QUIET for a company who announced they hired a PR company a few weeks ago. I really hope they unleash some big news soon and justify the reason they were hired .
0 · Reply
IronSpartan
IronSpartan May. 11 at 6:37 PM
$QNTM Quantum + pharma? interesting
0 · Reply
Rambler1111
Rambler1111 May. 11 at 6:36 PM
$QNTM
0 · Reply
MysticMorpheus
MysticMorpheus May. 10 at 8:15 PM
AMS 💎 If you ain't bullish enough here I don't know what to say! AMS trending #3 on Stocktwits, bullish as it gets. Life changing money will be made here next week, don't be left behind on this opportunity! $ACHR $QCOM $QNTM $ILLR ..ww8
0 · Reply
Vapor83
Vapor83 May. 9 at 1:59 PM
$QNTM guessing we get trial news this week and a 100% jump
0 · Reply
FickleFin
FickleFin May. 8 at 2:40 PM
$QNTM $GNS its called... leverage. Paid by retail investors. They pump. They pocket. This company is a lie. 2nd picture is 3 different aliases under 1 person stating the same narrative but cross tagging different tickers. 🚩🚩🚩🚩
1 · Reply
ZacksResearch
ZacksResearch May. 7 at 7:02 PM
$QNTM just doubled its liquidity — and the biotech pipeline is still moving full speed 🚀 💰 Cash, cash equivalents + digital assets jumped to $9.8M in Q1, up from $4.1M at year-end 📉 Operating cash burn dropped 60% YoY after Phase 1 trial completion 🧬 Lucid-MS IND officially submitted to the FDA, with Phase 2 plans advancing alongside Allucent Meanwhile, management says current liquidity could fund operations through approximately July 2027. See what Wall Street expects next 👉 https://www.zacks.com/stock/research/QNTM/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38021&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38021
1 · Reply
Ronin275
Ronin275 May. 7 at 12:04 PM
$QNTM https://feeds.issuerdirect.com/news-release.html?newsid=8057852677373016&symbol=QNTM
1 · Reply
FickleFin
FickleFin May. 7 at 10:27 AM
$QNTM $GNS Dilution is the solution. 😄😄😄🥴 red flag after red flag... then you get the pumps. Notice the pattern??
0 · Reply
Vapor83
Vapor83 May. 7 at 1:22 AM
$QNTM good pop coming soon
0 · Reply
Wearewhowethought
Wearewhowethought May. 6 at 9:39 PM
$GNS $MMTLP $QNTM rest a assure if there is any type of mmtlp payout that team of 60k shareholders is going buy yhe gns float and jamm it ip vitus a hole
0 · Reply
Wearewhowethought
Wearewhowethought May. 6 at 9:18 PM
$GNS $MMTLP $QNTM https://www.businesswire.com/news/home/20251117989078/en/Grant-Eisenhofer-Files-Class-Action-Lawsuit-Against-Citadel-Securities-LLC-and-Virtu-Americas-LLC
0 · Reply
Vapor83
Vapor83 May. 6 at 9:09 PM
$QNTM https://www.prnewswire.com/news-releases/fernando-mendoza-and-family-launch-mendoza-family-fund-with-national-ms-society-ahead-of-draft-day-302751790.html
0 · Reply